AIA
BSX icon

Arcadia Investment Advisors’s Boston Scientific BSX Stock Holding History

Arcadia Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22
Closed -$941 – 130
2021
Q2 		$941 Buy
+22
New +$926 ﹤0.01% 174

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Arcadia Investment Advisors's BSX Position: Q3 2021 in Review

Arcadia Investment Advisors sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 22 shares — an estimated $941 sold.

Arcadia Investment Advisors first reported a position in BSX in Q2 2021 and held it in 1 quarter. The position peaked at $941 in Q2 2021. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Arcadia Investment Advisors reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Arcadia Investment Advisors sold 22 Boston Scientific shares in Q3 2021, an estimated $941.
  • Arcadia Investment Advisors first reported a position in Boston Scientific in Q2 2021 and held it in 1 quarter.
  • Arcadia Investment Advisors's Boston Scientific position peaked at $941 in Q2 2021.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Arcadia Investment Advisors's 13F filing for Q3 2021, filed 19 Dec 2024.